Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-009234

Chairman, President & CEO sold 162,777 shares at an average $84.63 ($13,775,792)

  • Chairman, President & CEO acquired 111,886 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mahoney Michael F · Chairman, President & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-07 Exercise or conversion : show line 1 in the form 10b5-1 +56,211 $17.26 $970,202 1,679,198 D
2024-10-07 Exercise or conversion : show line 2 in the form 10b5-1 +55,675 $16.31 $908,059 1,734,873 D
2024-10-07 Sale : show line 3 in the form 10b5-1 −80,692 $84.31 $6,803,360 1,654,181 D
2024-10-07 Sale : show line 4 in the form 10b5-1 −82,085 $84.94 $6,972,431 1,572,096 D
Open-market sales · 162,777 sh · avg $84.63 · $13,775,792

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-10-07 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −56,211 224,846 D
2024-10-07 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −55,675 55,676 D
Loading xslF345X05/doc4.xml…